« Return to News | Awards & Advancement

Naurex completes $18 Million Series A

Wednesday, May 11, 2011 12:59 PM

Naurex, a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, has completed an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners. 

Naurex will use the proceeds from the Series A financing primarily for the phase II trial of its lead compound, GLYX-13, a glycine-site functional partial agonist (GFPA) selective modulator of the NMDA receptor (NMDAR), and also to advance its second-generation GFPA program. 

Naurex will also appoint Wilbur (Bill) Gantz of PathoCapital as chairman of Naurex's board of directors, a newly created position.  Previously, he was executive chairman of Ovation Pharmaceuticals.  Terry Gould of Adams Street Partners and Kenneth Widder, M.D., of Latterell Ventures are also joining as directors. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.